Biofrontera cancels admission of shares on AIM

20th Jan 2016 15:26

(ShareCast News) - Dermatology company Biofrontera on Wednesday said it was cancelling its admission of ordinary shares to trading on London Stock Exchange's AIM index from 18 February. The decision to cancel its shares on AIM follows a review by the board which showed a "very low volume of trading"

Read more